Hisamitsu Pharmaceutical Co Inc
TSE:4530
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Price:
3 823 JPY
1.16%
Market Closed
Updated:
Apr 30, 2024
Hisamitsu Pharmaceutical Co Inc
Operating Income
|
Hisamitsu Pharmaceutical Co Inc
Operating Income Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
Operating Income
¥15.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Income
¥464.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Income
¥188B
|
CAGR 3-Years
37%
|
CAGR 5-Years
19%
|
CAGR 10-Years
5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Income
¥294.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
32%
|
CAGR 10-Years
3%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Income
¥444.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Income
¥142B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
3%
|
See Also
What is Hisamitsu Pharmaceutical Co Inc's Operating Income?
Operating Income
15.2B
JPY
15.2B
JPY
Based on the financial report for Nov 30, 2023, Hisamitsu Pharmaceutical Co Inc's Operating Income amounts to 15.2B JPY.
What is Hisamitsu Pharmaceutical Co Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-4%
-4%
Over the last year, the Operating Income growth was 39%. The average annual Operating Income growth rates for Hisamitsu Pharmaceutical Co Inc have been 7% over the past three years , -7% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
